News | February 06, 2024
Unichem Laboratories posts Q3 FY24 consolidated PAT at Rs. 83.99 Cr
Unichem Laboratories has reported total income of Rs. 445.65 crores during the period ended December 31, 2023
Unichem Laboratories has reported total income of Rs. 445.65 crores during the period ended December 31, 2023
Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure
Prasugrel tablets are indicated to reduce the rate of thrombotic CV events
The business and product range of Ipca and that of Unichem complements each others business and product range
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
Extended Phenytoin Sodium Capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures
The company has received payment towards completion of sale of the first tranche from Sekhmet Pharmaventures Private Limited.
Carbamazepine Tablets are indicated for use as an anticonvulsant drug and in the treatment of the pain associated with true trigeminal neuralgia
Quetiapine Extended-Release Tablets are indicated for the treatment of Schizophrenia, Bipolar disorder and adjunctive treatment of Major Depressive Disorder (MDD)
The company has reported total income of Rs. 317.45 crores during the period ended June 30, 2022
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)